Cargando…
Corrigendum to “Sostdc1: A soluble BMP and Wnt antagonist that is induced by the interaction between myeloma cells and osteoblast lineage cells” [Bone 122 (May 2019) 82–92]
Autores principales: | Faraahi, Z., Baud'huin, M., Croucher, P.I., Eaton, C., Lawson, M.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548283/ https://www.ncbi.nlm.nih.gov/pubmed/31056460 http://dx.doi.org/10.1016/j.bone.2019.04.020 |
Ejemplares similares
-
Sostdc1: A soluble BMP and Wnt antagonist that is induced by the interaction between myeloma cells and osteoblast lineage cells
por: Faraahi, Z., et al.
Publicado: (2019) -
Investigation of the role of the miR17-92 cluster in BMP9-induced osteoblast lineage commitment
por: Zhang, Yunyuan, et al.
Publicado: (2021) -
Implication of the p53-Related miR-34c, -125b, and -203 in the Osteoblastic Differentiation and the Malignant Transformation of Bone Sarcomas
por: Jacques, Camille, et al.
Publicado: (2020) -
Characterization of the different oligomeric states of the DAN family antagonists SOSTDC1 and SOST
por: Gipson, Gregory R., et al.
Publicado: (2020) -
BMP3 expression by osteoblast lineage cells is regulated by canonical Wnt signaling
por: Kokabu, Shoichiro, et al.
Publicado: (2017)